Tag: Funding

Browse our exclusive articles!

Mistral AI Raises €105M in Europe’s Biggest Seed Funding Round.

Mistral AI secures €105m in Europe's largest-ever seed round, targeting enterprise AI solutions. Developing a large language model which is open-sourced, without legal issues and copyright infringement.

EU Funds Multiple Huawei Projects Despite European Ban.

Despite security concerns, the EU has reportedly funded Huawei for projects including 6G, AI, cloud computing, and more. Is this a wise investment?

Oracle Bets on Cohere as AI Rival to OpenAI

Oracle partners with Toronto-based AI startup, Cohere, to offer enterprise customers an alternative method to build generative AI apps using their own data. Cohere raised $270M in a series C funding round, with big tech names including NVIDIA, Salesforce Ventures, and SentinelOne. Oracle will be embedding Cohere's AI technology, and Cohere will use Oracle's cloud to train, build, and deploy its AI models. This partnership looks similar to Microsoft's investment in OpenAI, but Cohere is designed for enterprise customers, allowing them to use their own data to train their AI models without sharing it.

Generative AI Startup Synthesia Raises $90 Million at $1 Billion Valuation from Accel and Nvidia

Discover London-based startup Synthesia, revolutionizing the world of generative AI with their virtual avatar technology. With $90m raised, this unicorn valuation is one to watch! #Synthesia #AI #startup

Basics of Paid Acquisition, Top-Valued Startups and 10 Investors Open to Pitches: TechCrunch+ Roundup

Get the inside scoop on paid acquisition, startup failures, and fundraising from TechCrunch+. Discover the latest trends and insights in the tech industry. Subscribe now and save 20% with code TCPLUSROUNDUP.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img